TABLE 3.
Clinical parameters in the 51 patients which reached the 5 years examination (means ± SD)
| Baseline | 1 year | 5 years | p value | |||
|---|---|---|---|---|---|---|
| Baseline vs 1 year | 1 year vs 5 years | Baseline vs 5 years | ||||
| PD (mm)∋ | 6.89 ± 1.58 | 3.82 ± 1.07 | 4.06 ± 1.12 | <0.001 | 0.332 | <0.001 |
| PD≥6 (mm)∋ | 2.80 ± 0.96 | 0.45 ± 1.05 | 0.63 ± 1.13 | <0.001 | 0.661 | <0.001 |
| Deepest PD (mm)∋ | 8.92 ± 1.89 | 4.65 ± 1.40 | 5.02 ± 1.44 | <0.001 | 0.177 | <0.001 |
| KT (mm)∋ | 3.37 ± 1.41 | 2.76 ± 1.31 | 2.78 ± 1.19 | 0.008 | 1.000 | 0.007 |
| REC (mm)∋ | – | 0.69 ± 0.79 | 0.69 ± 0.79 | – | 1.000 | – |
| BOP at the implant site (%)∋ | 70.6 ± 34.9 | 9.3 ± 18.7 | 17.2 ± 22.1 | <0.001 | 0.054 | <0.001 |
| Pl at the implant site (%)∋ | 13.2 ± 24.2 | 5.9 ± 13.8 | 15.7 ± 23.4 | 0.090 | 0.020 | 1.000 |
| Pus (%)# | 15 (29.4) | 1 (2.0) | 3 (5.9) | <0.001 | 1.000 | 0.013 |
Abbreviations: BOP, Bleeding on probing at the implant site; Pl, Plaque at the implant site.
∋Wilcoxon test with Bonferroni´s correction.
#McNemar test with Bonferroni´s correction.